These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37423567)

  • 41. The role of 18F fluorodeoxyglucose positron emission tomography (18F-FDG-PET) in children with rheumatic carditis and chronic rheumatic heart disease.
    Nagesh CM; Saxena A; Patel C; Karunanithi S; Nadig M; Malhotra A
    Nucl Med Rev Cent East Eur; 2015; 18(1):25-8. PubMed ID: 25633513
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Myocarditis-like Episodes in Patients with Arrhythmogenic Cardiomyopathy: A Systematic Review on the So-Called Hot-Phase of the Disease.
    Bariani R; Rigato I; Cipriani A; Bueno Marinas M; Celeghin R; Basso C; Corrado D; Pilichou K; Bauce B
    Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139162
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility.
    Basu S; Li G; Bural G; Alavi A
    Acta Radiol; 2009 Mar; 50(2):201-4. PubMed ID: 19089692
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Suppression of Myocardial 18F-FDG Uptake Through Prolonged High-Fat, High-Protein, and Very-Low-Carbohydrate Diet Before FDG-PET/CT for Evaluation of Patients With Suspected Cardiac Sarcoidosis.
    Lu Y; Grant C; Xie K; Sweiss NJ
    Clin Nucl Med; 2017 Feb; 42(2):88-94. PubMed ID: 27922863
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Positron emission tomography in clinically suspected myocarditis - STREAM study design.
    Ozierański K; Tymińska A; Kobylecka M; Caforio ALP; Šobić-Šaranović D; Ristić AD; Maksimović R; Seferović PM; Marcolongo R; Królicki L; Opolski G; Grabowski M
    Int J Cardiol; 2021 Jun; 332():113-118. PubMed ID: 33657398
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of qualitative and quantitative analysis of F18-FDG positron emission tomography in predicting pathologic response following chemoradiotherapy in patients with esophageal carcinoma.
    Klayton T; Li T; Yu JQ; Keller L; Cheng J; Cohen SJ; Meropol NJ; Scott W; Xu-Welliver M; Konski A
    J Gastrointest Cancer; 2012 Dec; 43(4):612-8. PubMed ID: 22777832
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quantifying the Area at Risk in Reperfused ST-Segment-Elevation Myocardial Infarction Patients Using Hybrid Cardiac Positron Emission Tomography-Magnetic Resonance Imaging.
    Bulluck H; White SK; Fröhlich GM; Casson SG; O'Meara C; Newton A; Nicholas J; Weale P; Wan SM; Sirker A; Moon JC; Yellon DM; Groves A; Menezes L; Hausenloy DJ
    Circ Cardiovasc Imaging; 2016 Mar; 9(3):e003900. PubMed ID: 26926269
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recurrent acute myocarditis: An under-recognized clinical entity associated with the later diagnosis of a genetic arrhythmogenic cardiomyopathy.
    Ollitrault P; Al Khoury M; Troadec Y; Calcagno Y; Champ-Rigot L; Ferchaud V; Pellissier A; Legallois D; Milliez P; Labombarda F
    Front Cardiovasc Med; 2022; 9():998883. PubMed ID: 36386348
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.
    Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hybrid positron emission tomography-magnetic resonance imaging for assessing different stages of cardiac impairment in patients with Anderson-Fabry disease: AFFINITY study group.
    Imbriaco M; Nappi C; Ponsiglione A; Pisani A; Dell'Aversana S; Nicolai E; Spinelli L; Aiello M; Diomiaiuti CT; Riccio E; Esposito R; Galderisi M; Losi M; Greiser A; Chow K; Cuocolo A
    Eur Heart J Cardiovasc Imaging; 2019 Sep; 20(9):1004-1011. PubMed ID: 30879055
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic Importance of Bone Marrow Uptake on Baseline
    Soydal C; Koksoy EB; Yasar A; Turgal E; Erdogan BD; Akbulut H; Kucuk NO
    Cancer Biother Radiopharm; 2016 Dec; 31(10):361-365. PubMed ID: 27996313
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnosis of myocardial viability by dual-head coincidence gamma camera fluorine-18 fluorodeoxyglucose positron emission tomography with and without non-uniform attenuation correction.
    Nowak B; Zimny M; Schwarz ER; Kaiser HJ; Schaefer W; Reinartz P; vom Dahl J; Buell U
    Eur J Nucl Med; 2000 Oct; 27(10):1501-8. PubMed ID: 11083539
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of cardiac MRI and 18F-FDG positron emission tomography manifestations and regional response to corticosteroid therapy in newly diagnosed cardiac sarcoidosis with complet heart block.
    Orii M; Hirata K; Tanimoto T; Ota S; Shiono Y; Yamano T; Matsuo Y; Ino Y; Yamaguchi T; Kubo T; Tanaka A; Akasaka T
    Heart Rhythm; 2015 Dec; 12(12):2477-85. PubMed ID: 26111805
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 18F-FDG PET/CT findings of radiotherapy-related myocardial changes in patients with thoracic malignancies.
    Unal K; Unlu M; Akdemir O; Akmansu M
    Nucl Med Commun; 2013 Sep; 34(9):855-9. PubMed ID: 23728520
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cardiac ¹⁸F-fluorodeoxyglucose uptake on positron emission tomography after thoracic stereotactic body radiation therapy.
    Evans JD; Gomez DR; Chang JY; Gladish GW; Erasmus JJ; Rebueno N; Banchs J; Komaki R; Welsh JW
    Radiother Oncol; 2013 Oct; 109(1):82-8. PubMed ID: 24016676
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acquisition, Processing, and Interpretation of PET
    Celiker-Guler E; Ruddy TD; Wells RG
    Curr Cardiol Rep; 2021 Jul; 23(9):124. PubMed ID: 34269917
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The utility of beta-hydroxybutyrate in detecting myocardial glucose uptake suppression in patients undergoing inflammatory [18F]-FDG PET studies.
    Alfawara MS; Ahmed AI; Saad JM; Han Y; Alahdab F; Al Rifai M; Kassi M; Alnabelsi T; Zoghbi WA; Al-Mallah MH
    Eur J Nucl Med Mol Imaging; 2023 Mar; 50(4):1103-1110. PubMed ID: 36474124
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography scan contributes to the diagnosis and management of brucellar spondylodiskitis.
    Ioannou S; Chatziioannou S; Pneumaticos SG; Zormpala A; Sipsas NV
    BMC Infect Dis; 2013 Feb; 13():73. PubMed ID: 23388066
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.
    Knopman DS; Jack CR; Wiste HJ; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC
    Neurobiol Aging; 2014 Sep; 35(9):2096-106. PubMed ID: 24702820
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The significance and management of incidental [18F]fluorodeoxyglucose-positron-emission tomography uptake in the thyroid gland in patients with cancer.
    Eloy JA; Brett EM; Fatterpekar GM; Kostakoglu L; Som PM; Desai SC; Genden EM
    AJNR Am J Neuroradiol; 2009 Aug; 30(7):1431-4. PubMed ID: 19342543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.